Biglycan Antikörper
Kurzübersicht für Biglycan Antikörper (ABIN7635369)
Target
Alle Biglycan (BGN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Monoclonal Antibody to Biglycan (BGN)
-
Spezifität
- The antibody is a mouse monoclonal antibody raised against BGN. It has been selected for its ability to recognize BGN in immunohistochemical staining and western blotting.
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
anti-Biglycan (BGN) (AA 1-368) antibody
BGN Reaktivität: Human WB, IP, ELISA, IHC (p) Wirt: Maus Monoclonal 4E1-1G7 unconjugated
anti-Biglycan (BGN) (AA 230-366) antibodyBGN Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 53-166) antibodyBGN Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (C-Term) antibodyVerified BGN Reaktivität: Human, Maus ELISA, IF Wirt: Ziege Polyclonal unconjugated
anti-Biglycan (BGN) (AA 101-200) antibodyBGN Reaktivität: Human, Ratte, Maus, Kaninchen WB, ELISA, FACS, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 148-176) antibodyBGN Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB19735 unconjugated
anti-Biglycan (BGN) (AA 38-300) antibodyBGN Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 20-230) antibodyBGN Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (C-Term) antibodyBGN Reaktivität: Human, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 1-368) antibodyBGN Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Western blotting: 0.2-2 μg/mL,1:500-5000 Immunohistochemistry: 5-20 μg/mL,1:50-200 Immunocytochemistry: 5-20 μg/mL,1:50-200 Optimal working dilutions must be determined by end user.
-
Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
-
- Biglycan (BGN)
-
Andere Bezeichnung
- Biglycan
-
Hintergrund
- DSPG1, PG-S1, PGI, SLRR1A, Biglycan Proteoglycan, Bone/cartilage proteoglycan I
-
UniProt
- P47853
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-
